ACM
WST icon

Aquatic Capital Management’s West Pharmaceutical WST Stock Holding History

Aquatic Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,314
Closed -$4.21M – 1863
2025
Q4 		$4.21M Buy
+15,314
New +$4.19M 0.12% 209
2024
Q3 		– Sell
-9,520
Closed -$3.14M – 1589
2024
Q2 		$3.14M Buy
+9,520
New +$3.36M 0.12% 182
2024
Q1 		– Sell
-14,480
Closed -$5.1M – 1702
2023
Q4 		$5.1M Buy
14,480
+13,680
+1,710% +$4.84M 0.13% 170
2023
Q3 		$300K Sell
800
-4,800
-86% -$1.86M 0.01% 590
2023
Q2 		$2.14M Buy
+5,600
New +$2M 0.12% 193
2023
Q1 		– Sell
-9,300
Closed -$2.19M – 1811
2022
Q4 		$2.19M Buy
9,300
+3,200
+52% +$758K 0.16% 147
2022
Q3 		$1.5M Buy
6,100
+5,400
+771% +$1.65M 0.15% 192
2022
Q2 		$212K Buy
700
+500
+250% +$163K 0.07% 323
2022
Q1 		$82K Buy
+200
New +$78.3K 0.12% 190

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aquatic Capital Management's WST Position: Q1 2026 in Review

Aquatic Capital Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 15,314 shares — an estimated $4.21M sold.

Aquatic Capital Management first reported a position in WST in Q1 2022 and held it in 9 quarters. The position peaked at $5.1M in Q4 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Aquatic Capital Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 15,314 West Pharmaceutical shares in Q1 2026, an estimated $4.21M.
  • Aquatic Capital Management first reported a position in West Pharmaceutical in Q1 2022 and held it in 9 quarters.
  • Aquatic Capital Management's West Pharmaceutical position peaked at $5.1M in Q4 2023.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.